Literature DB >> 1908953

Relationship of primary structure to functional properties of the cytotoxin protein from Pseudomonas aeruginosa.

G M Xiong1, M Struckmeier, U Alberti, F Lutz.   

Abstract

Deletion mutants of plasmid pSN3 carrying the Pseudomonas aeruginosa cytotoxin gene were prepared and expression in Escherichia coli of proteins with different molecular weights has been proved by Western blot. In addition, through PCR amplification of the cytotoxin gene and ligation into the vector, a single nucleotide change leading to an amino acid exchange from histidine to arginine has been constructed. The activities of the mutants were tested by binding of 125I-cytotoxin to rabbit erythrocyte ghosts and swelling of human granulocytes, showing that the cytotoxin activity is dependent on at least three different domains. Amino acids 12-20 from the C-terminus might be very important for proteolytic activation of protoxin to toxin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908953     DOI: 10.1007/bf00169558

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  14 in total

1.  Purification of a cytotoxic protein from Pseudomonas aeruginosa.

Authors:  F Lutz
Journal:  Toxicon       Date:  1979       Impact factor: 3.033

2.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

3.  Staphylococcal leucocidins.

Authors:  G P GLADSTONE; W E VAN HEYNINGEN
Journal:  Br J Exp Pathol       Date:  1957-04

4.  Pore-forming cytotoxin of Pseudomonas aeruginosa: the molecular effects and aspects of pathogenicity.

Authors:  F Lutz; G Xiong; R Jungblut; G Orlik-Eisel; A Göbel-Reifert; R Leidolf
Journal:  Antibiot Chemother (1971)       Date:  1991

5.  Electrophoretic resolution of the "major outer membrane protein" of Escherichia coli K12 into four bands.

Authors:  B Lugtenberg; J Meijers; R Peters; P van der Hoek; L van Alphen
Journal:  FEBS Lett       Date:  1975-10-15       Impact factor: 4.124

6.  Interaction of Pseudomonas aeruginosa cytotoxin with plasma membranes from Ehrlich ascites tumor cells.

Authors:  F Lutz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

7.  Inside-out red cell membrane vesicles: preparation and purification.

Authors:  T L Steck; R S Weinstein; J H Straus; D F Wallach
Journal:  Science       Date:  1970-04-10       Impact factor: 47.728

8.  Cytotoxic protein from Pseudomonas aeruginosa: formation of hydrophilic pores in Ehrlich ascites tumor cells and effect on cell viability.

Authors:  F Lutz; M Maurer; K Failing
Journal:  Toxicon       Date:  1987       Impact factor: 3.033

9.  Pseudomonas aeruginosa cytotoxin: the nucleotide sequence of the gene and the mechanism of activation of the protoxin.

Authors:  T Hayashi; Y Kamio; F Hishinuma; Y Usami; K Titani; Y Terawaki
Journal:  Mol Microbiol       Date:  1989-07       Impact factor: 3.501

10.  Phage-conversion of cytotoxin production in Pseudomonas aeruginosa.

Authors:  T Hayashi; T Baba; H Matsumoto; Y Terawaki
Journal:  Mol Microbiol       Date:  1990-10       Impact factor: 3.501

View more
  3 in total

1.  Nucleotide sequence of attP and cos sites of phage CTX and expression of cytotoxin in Pseudomonas aeruginosa PA158.

Authors:  H Elsabbagh; G Xiong; F Lutz
Journal:  Mol Gen Genet       Date:  1993-03

2.  Site-specific integration of the phage phi CTX genome into the Pseudomonas aeruginosa chromosome: characterization of the functional integrase gene located close to and upstream of attP.

Authors:  Z Wang; G Xiong; F Lutz
Journal:  Mol Gen Genet       Date:  1995-01-06

3.  Pseudomonas aeruginosa cytotoxin: the Asp197-Gly-Asp-Tyr-His-Tyr-His-Tyr202 containing loop is critical for plasma membrane binding.

Authors:  M Struckmeier; G Xiong; F Lutz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-03       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.